Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 28

References for PMC Articles for PubMed (Select 20870313)

1.
2.

Identification of novel small-molecule agonists for human formyl peptide receptors and pharmacophore models of their recognition.

Kirpotina LN, Khlebnikov AI, Schepetkin IA, Ye RD, Rabiet MJ, Jutila MA, Quinn MT.

Mol Pharmacol. 2010 Feb;77(2):159-70. doi: 10.1124/mol.109.060673. Epub 2009 Nov 10.

3.

6-methyl-2,4-disubstituted pyridazin-3(2H)-ones: a novel class of small-molecule agonists for formyl peptide receptors.

Cilibrizzi A, Quinn MT, Kirpotina LN, Schepetkin IA, Holderness J, Ye RD, Rabiet MJ, Biancalani C, Cesari N, Graziano A, Vergelli C, Pieretti S, Dal Piaz V, Giovannoni MP.

J Med Chem. 2009 Aug 27;52(16):5044-57. doi: 10.1021/jm900592h.

4.

International Union of Basic and Clinical Pharmacology. LXXIII. Nomenclature for the formyl peptide receptor (FPR) family.

Ye RD, Boulay F, Wang JM, Dahlgren C, Gerard C, Parmentier M, Serhan CN, Murphy PM.

Pharmacol Rev. 2009 Jun;61(2):119-61. doi: 10.1124/pr.109.001578. Epub 2009 Jun 4. Review.

5.

APIF: a new interaction fingerprint based on atom pairs and its application to virtual screening.

Pérez-Nueno VI, Rabal O, Borrell JI, Teixidó J.

J Chem Inf Model. 2009 May;49(5):1245-60. doi: 10.1021/ci900043r.

PMID:
19364101
6.

Efficient exploration of large combinatorial chemistry spaces by monomer-based similarity searching.

Yu N, Bakken GA.

J Chem Inf Model. 2009 Apr;49(4):745-55. doi: 10.1021/ci800392z.

PMID:
19309177
7.

Applications of 2D descriptors in drug design: a DRAGON tale.

Helguera AM, Combes RD, González MP, Cordeiro MN.

Curr Top Med Chem. 2008;8(18):1628-55. Review.

PMID:
19075771
8.

Binary classification models for endocrine disrupter effects mediated through the estrogen receptor.

Roncaglioni A, Piclin N, Pintore M, Benfenati E.

SAR QSAR Environ Res. 2008;19(7-8):697-733. doi: 10.1080/10629360802550606.

PMID:
19061085
9.

Computational structure-activity relationship analysis of non-peptide inducers of macrophage tumor necrosis factor-alpha production.

Khlebnikov AI, Schepetkin IA, Kirpotina LN, Quinn MT.

Bioorg Med Chem. 2008 Oct 15;16(20):9302-12. doi: 10.1016/j.bmc.2008.08.078. Epub 2008 Sep 5.

10.

Identification of novel formyl peptide receptor-like 1 agonists that induce macrophage tumor necrosis factor alpha production.

Schepetkin IA, Kirpotina LN, Tian J, Khlebnikov AI, Ye RD, Quinn MT.

Mol Pharmacol. 2008 Aug;74(2):392-402. doi: 10.1124/mol.108.046946. Epub 2008 May 5.

11.

Structure-activity relationship analysis of N-benzoylpyrazoles for elastase inhibitory activity: a simplified approach using atom pair descriptors.

Khlebnikov AI, Schepetkin IA, Quinn MT.

Bioorg Med Chem. 2008 Mar 15;16(6):2791-802. doi: 10.1016/j.bmc.2008.01.014. Epub 2008 Jan 15.

12.

New 'chemical probes' to examine the role of the hFPRL1 (or ALXR) receptor in inflammation.

Frohn M, Xu H, Zou X, Chang C, McElvaine M, Plant MH, Wong M, Tagari P, Hungate R, Bürli RW.

Bioorg Med Chem Lett. 2007 Dec 1;17(23):6633-7. Epub 2007 Sep 15.

PMID:
17920884
13.

Structure-activity relationship study of oxindole-based inhibitors of cyclin-dependent kinases based on least-squares support vector machines.

Li J, Liu H, Yao X, Liu M, Hu Z, Fan B.

Anal Chim Acta. 2007 Jan 9;581(2):333-42. Epub 2006 Aug 24.

PMID:
17386461
14.

Target specific compound identification using a support vector machine.

Plewczynski D, von Grotthuss M, Spieser SA, Rychlewski L, Wyrwicz LS, Ginalski K, Koch U.

Comb Chem High Throughput Screen. 2007 Mar;10(3):189-96.

PMID:
17346118
15.

High-throughput screening for small-molecule activators of neutrophils: identification of novel N-formyl peptide receptor agonists.

Schepetkin IA, Kirpotina LN, Khlebnikov AI, Quinn MT.

Mol Pharmacol. 2007 Apr;71(4):1061-74. Epub 2007 Jan 17.

16.

Learning from the data: mining of large high-throughput screening databases.

Yan SF, King FJ, He Y, Caldwell JS, Zhou Y.

J Chem Inf Model. 2006 Nov-Dec;46(6):2381-95.

PMID:
17125181
17.

Representation of molecular structure using quantum topology with inductive logic programming in structure-activity relationships.

Buttingsrud B, Ryeng E, King RD, Alsberg BK.

J Comput Aided Mol Des. 2006 Jun;20(6):361-73. Epub 2006 Oct 13.

PMID:
17054018
18.

Potent hFPRL1 (ALXR) agonists as potential anti-inflammatory agents.

Bürli RW, Xu H, Zou X, Muller K, Golden J, Frohn M, Adlam M, Plant MH, Wong M, McElvain M, Regal K, Viswanadhan VN, Tagari P, Hungate R.

Bioorg Med Chem Lett. 2006 Jul 15;16(14):3713-8. Epub 2006 May 11.

PMID:
16697190
19.
20.

Integration of virtual screening with high-throughput flow cytometry to identify novel small molecule formylpeptide receptor antagonists.

Edwards BS, Bologa C, Young SM, Balakin KV, Prossnitz ER, Savchuck NP, Sklar LA, Oprea TI.

Mol Pharmacol. 2005 Nov;68(5):1301-10. Epub 2005 Aug 23.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk